The pharmaceutical landscape for blood sugar is changing, and GLP-1 patches represent a potential development. Unlike shots, this approach offers a less invasive way to administer GLP-1 medications. These patches steadily release the drug through the skin offering a even amount of the beneficial agent, which can optimize glucose control and possibl